These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4152320)

  • 1. In vitro effects of iodinated arthrographic contrast media on bacterial growth.
    Melson GL; McDaniel RC; Southern PM; Staple TW
    Radiology; 1974 Sep; 112(3):593-5. PubMed ID: 4152320
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.
    Steigbigel NH; Reed CW; Finland M
    Am J Med Sci; 1968 Mar; 255():179-95. PubMed ID: 4384524
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic resistance in general practice.
    Hammond L
    Aust Fam Physician; 1990 May; 19(5):723-4, 727, 730-1. PubMed ID: 2111984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

  • 8. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Tsuchiya K; Kondo M; Oishi T; Yamazaki I
    J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
    Beeuwkes H; Buytendijk HJ; Maesen FP
    Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183
    [No Abstract]   [Full Text] [Related]  

  • 11. 6 -amidinopenicillanic acids--a new group of antibiotics.
    Lund F; Tybring L
    Nat New Biol; 1972 Apr; 236(66):135-7. PubMed ID: 4402006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of antibacterial activity of cephapirin with cephalothin and cephaloridine to various pathogenic bacteria recently isolated from clinical materials (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1974 Apr; 27(2):157-63. PubMed ID: 4211361
    [No Abstract]   [Full Text] [Related]  

  • 13. An in vitro and pharmacological comparison of amoxicillin and ampicillin.
    Brusch JL; Bergeron MG; Barza M; Weinstein L
    Am J Med Sci; 1974 Jan; 267(1):41-8. PubMed ID: 4150176
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro antimicrobial activity of 6(D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid, a new semisynthetic penicillin.
    Neu HC; Winshell EB
    Antimicrob Agents Chemother (Bethesda); 1970; 10():407-10. PubMed ID: 4398823
    [No Abstract]   [Full Text] [Related]  

  • 15. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
    Hall MJ; Westmacott D; Wong-Kai-In P
    J Antimicrob Chemother; 1981 Sep; 8(3):193-203. PubMed ID: 6270051
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriostatic effect of tetracyclines-macrolides associations].
    de Lajudie P
    Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.